Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Zhou

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 28, 2013
Comparison of tumor neovasculature-targeted paramagnetic nanoliposomes for MRI in mice xenograft modelsQ-H Xu, J-Y Shi, J Zhang, et al.
Journal of Applied Microbiology|October 26, 2019
Investigation of Streptococcus agalactiae using pcsB-based LAMP in milk, tilapia and vaginal swabs in Haikou, ChinaW Pu, Y Wang, N Yang, et al.
Oncogene|April 12, 2016
Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374aF Liu, J-H Yuan, J-F Huang, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology|January 28, 2026
[Expert consensus on the application of artificial intelligence in stomatology]Y Wei, Y J Wu, J J Deng, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2012
Second-line pemetrexed versus docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer: a randomized, open-label studyY Sun, Y-L Wu, C-C Zhou, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|June 21, 2019
[Clinical analysis of 555 outpatients with hand, foot and mouth diseases caused by different enteroviruses]P Cui, Y Li, C C Zhou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2026
Izalontamab brengitecan (Iza-bren; BL-B01D1), a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, for patients with EGFR-mutated NSCLC: Pooled analysis of phase 1 and phase 2 trialsS-D Hong, Y-S Wang, H-Y Zhao, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 28, 2013
Comparison of tumor neovasculature-targeted paramagnetic nanoliposomes for MRI in mice xenograft modelsQ-H Xu, J-Y Shi, J Zhang, et al.
Journal of Applied Microbiology|October 26, 2019
Investigation of Streptococcus agalactiae using pcsB-based LAMP in milk, tilapia and vaginal swabs in Haikou, ChinaW Pu, Y Wang, N Yang, et al.
Oncogene|April 12, 2016
Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374aF Liu, J-H Yuan, J-F Huang, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology|January 28, 2026
[Expert consensus on the application of artificial intelligence in stomatology]Y Wei, Y J Wu, J J Deng, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2012
Second-line pemetrexed versus docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer: a randomized, open-label studyY Sun, Y-L Wu, C-C Zhou, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|June 21, 2019
[Clinical analysis of 555 outpatients with hand, foot and mouth diseases caused by different enteroviruses]P Cui, Y Li, C C Zhou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2026
Izalontamab brengitecan (Iza-bren; BL-B01D1), a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, for patients with EGFR-mutated NSCLC: Pooled analysis of phase 1 and phase 2 trialsS-D Hong, Y-S Wang, H-Y Zhao, et al.
Pageof 3